Ganirelix is an injectable medication that prevents premature ovulation during fertility treatments like IVF. It works by blocking a hormone signal in your brain that would otherwise trigger your ovaries to release eggs too early, before they can be retrieved by your fertility doctor. The standard dose is 250 micrograms given once daily as a subcutaneous injection, typically in the abdomen near the navel or the upper thigh.
How Ganirelix Works in Your Body
Your brain naturally releases a hormone called GnRH (gonadotropin-releasing hormone), which tells your pituitary gland to produce two key reproductive hormones: LH (luteinizing hormone) and FSH (follicle-stimulating hormone). A surge in LH is what triggers ovulation. During IVF, your doctor stimulates your ovaries with medications to grow multiple eggs at once, but those eggs need to stay put until they’re mature enough to be collected. If your body releases an LH surge on its own schedule, you could ovulate before the retrieval procedure, which would cancel the cycle.
Ganirelix is a GnRH antagonist, meaning it attaches to the same receptors in your pituitary gland that GnRH normally binds to, effectively blocking the signal. This suppresses LH quickly and keeps your ovaries from releasing eggs prematurely. Unlike some older medications used for the same purpose, ganirelix works almost immediately after the first injection rather than requiring weeks of buildup.
When You Start and How Long You Take It
You won’t start ganirelix on day one of your IVF cycle. First, you begin ovarian stimulation medications (typically on day 2 or 3 of your cycle) to encourage multiple follicles to grow. Ganirelix is then added during the mid to late follicular phase, once your follicles reach a certain size. In clinical protocols, doctors typically start ganirelix when one or more follicles measure 12 to 14 millimeters on ultrasound. Your clinic may use a fixed start day (often cycle day 5 or 6 of stimulation) or a flexible approach based on your follicle growth.
You continue the daily injection until your doctor determines that your eggs are mature enough for retrieval, at which point you receive a “trigger shot” to finalize egg maturation. Most people take ganirelix for roughly 4 to 5 days, though this varies depending on how quickly your follicles develop. The drug has a half-life of about 13 hours, and your hormone levels return to normal within two days of your last injection.
How to Give Yourself the Injection
Ganirelix comes in a prefilled syringe, which simplifies the process. You inject it subcutaneously, meaning just under the skin rather than into muscle. The most common injection sites are the lower abdomen (a few inches from the navel) or the upper thigh. Rotating your injection site each day helps reduce skin irritation. The needle is small, and most people find the injection itself quick and tolerable.
Store the medication at room temperature (around 77°F) and protect it from light. It does not need to be refrigerated, which makes it easier to handle than some other fertility medications. Try to give your injection at roughly the same time each day to maintain consistent hormone suppression.
Side Effects
The most noticeable side effect is irritation at the injection site. In clinical trials, 12 to 20 percent of patients experienced redness, bruising, pain, or itching within an hour of injection, though only about 2 percent had reactions considered moderate or severe. These typically resolve on their own.
Systemic side effects are less common. Pooled data from trials involving 792 women undergoing IVF found that headache, general malaise, and nausea each occurred in about 2 to 3 percent of patients. In one smaller trial, abdominal distension (bloating) was the most frequently reported issue, affecting about 12.5 percent of participants, though this can also be a symptom of the ovarian stimulation itself rather than ganirelix specifically.
Allergic reactions are rare but possible. Your fertility team will ask about any known allergies before prescribing ganirelix and will monitor you for signs of hypersensitivity during treatment.
How It Compares to Older Protocols
Before GnRH antagonists like ganirelix became widely available, most IVF protocols used GnRH agonists (such as leuprolide) to prevent premature ovulation. The key difference is timing. Agonist protocols require you to start injections weeks before ovarian stimulation begins, often adding 10 to 14 days of extra medication. Ganirelix protocols are shorter overall because the drug is only introduced once stimulation is already underway, meaning fewer total injections and a compressed treatment timeline.
Clinical trials comparing the two approaches found similar pregnancy rates. The practical advantage of ganirelix is the convenience of a shorter protocol with less time on medication. Antagonist protocols also offer doctors more flexibility in triggering final egg maturation, which can be useful for patients at higher risk of ovarian hyperstimulation syndrome.
Why Timing Matters So Much
The entire purpose of ganirelix is to give your fertility team control over when ovulation happens. In a natural cycle, your body decides when to release that LH surge, and the timing can vary from cycle to cycle. During IVF, eggs need to be collected at a precise window: mature enough to fertilize but not yet released from the follicles. Even a premature LH surge that doesn’t result in full ovulation can compromise egg quality or make retrieval more difficult. By suppressing that surge reliably, ganirelix helps ensure that the days of ovarian stimulation and monitoring translate into a successful egg retrieval. A daily dose of 0.25 mg was selected during development specifically because it was the minimum effective dose to prevent premature LH surges while yielding the highest ongoing pregnancy rate per cycle.